Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317435897> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W4317435897 endingPage "473" @default.
- W4317435897 startingPage "466" @default.
- W4317435897 abstract "Abstract Enoxaparin is the preferred treatment for venous thromboembolism (VTE) prophylaxis in trauma patients, but timing of initiation, optimal dosing, and therapeutic drug monitoring remain controversial. The objective of this study was to evaluate enoxaparin VTE prophylaxis practices in adult trauma patients across trauma centers in the United States and compare results to current guideline recommendations. An online survey designed by the study investigators was sent to pharmacist members of the American College of Clinical Pharmacy (ACCP) Critical Care Practice Research Network (PRN) and residency directors of institutions with accredited Critical Care Pharmacy Residency programs in the fall of 2021. This survey queried pharmacists' self‐reported practices regarding enoxaparin dosing and monitoring in trauma patients. One hundred five responses were collected with an estimated response rate of 5.3%. Most respondents reported using a standard enoxaparin dose of 30 mg subcutaneously (SUBQ) every 12 h (67%; 70/104) in trauma patients with normal renal function and higher initial dosing for obese trauma patients (75%; 78/104). The most common body mass index (BMI) threshold for dose adjustments in obesity was a BMI ≥40 kg/m 2 ; whereas 100 kg or more was commonly reported for a weight threshold. Multiple alternative enoxaparin dosing regimens were reported for obese and overweight patients. Of respondents who monitor anti‐Factor Xa (anti‐Xa) levels, 84% (61/73) reported monitoring peak levels with 47% (29/61) targeting a peak anti‐Xa goal of 0.2–0.4 units/ml. Seventy‐five percent (51/68) of respondents who adjust enoxaparin dosing based on anti‐Xa level monitoring reported adjusting doses by increments of 10 mg SUBQ every 12 h, and 41% (28/68) indicated having a pharmacist‐driven protocol for dose adjustments. Significant variation exists in enoxaparin dosing and monitoring strategies for VTE prophylaxis. Consensus among clinical practice guidelines is needed to standardize practice nationally." @default.
- W4317435897 created "2023-01-19" @default.
- W4317435897 creator A5013604366 @default.
- W4317435897 creator A5029775509 @default.
- W4317435897 creator A5042078488 @default.
- W4317435897 creator A5049682786 @default.
- W4317435897 creator A5058125903 @default.
- W4317435897 creator A5085569306 @default.
- W4317435897 date "2023-01-29" @default.
- W4317435897 modified "2023-09-26" @default.
- W4317435897 title "A survey of critical care pharmacists on venous thromboembolism prophylaxis dosing practices with enoxaparin in adult trauma patients" @default.
- W4317435897 cites W1986889371 @default.
- W4317435897 cites W1999023440 @default.
- W4317435897 cites W2040548093 @default.
- W4317435897 cites W2175097202 @default.
- W4317435897 cites W2286039737 @default.
- W4317435897 cites W2316042705 @default.
- W4317435897 cites W2321628844 @default.
- W4317435897 cites W2322068631 @default.
- W4317435897 cites W2462315700 @default.
- W4317435897 cites W2516272876 @default.
- W4317435897 cites W2765937089 @default.
- W4317435897 cites W2944967372 @default.
- W4317435897 cites W3037023615 @default.
- W4317435897 cites W3037376963 @default.
- W4317435897 cites W3086705822 @default.
- W4317435897 cites W3097326238 @default.
- W4317435897 cites W3116624809 @default.
- W4317435897 cites W3130793176 @default.
- W4317435897 cites W3155553283 @default.
- W4317435897 cites W3158155379 @default.
- W4317435897 cites W4210762282 @default.
- W4317435897 cites W4225472119 @default.
- W4317435897 cites W4225633094 @default.
- W4317435897 cites W4225974017 @default.
- W4317435897 doi "https://doi.org/10.1002/jac5.1758" @default.
- W4317435897 hasPublicationYear "2023" @default.
- W4317435897 type Work @default.
- W4317435897 citedByCount "1" @default.
- W4317435897 countsByYear W43174358972023 @default.
- W4317435897 crossrefType "journal-article" @default.
- W4317435897 hasAuthorship W4317435897A5013604366 @default.
- W4317435897 hasAuthorship W4317435897A5029775509 @default.
- W4317435897 hasAuthorship W4317435897A5042078488 @default.
- W4317435897 hasAuthorship W4317435897A5049682786 @default.
- W4317435897 hasAuthorship W4317435897A5058125903 @default.
- W4317435897 hasAuthorship W4317435897A5085569306 @default.
- W4317435897 hasConcept C104863432 @default.
- W4317435897 hasConcept C126322002 @default.
- W4317435897 hasConcept C142724271 @default.
- W4317435897 hasConcept C194828623 @default.
- W4317435897 hasConcept C2777288759 @default.
- W4317435897 hasConcept C2779457091 @default.
- W4317435897 hasConcept C2780182762 @default.
- W4317435897 hasConcept C2780221984 @default.
- W4317435897 hasConcept C2780586474 @default.
- W4317435897 hasConcept C2780868729 @default.
- W4317435897 hasConcept C2991741193 @default.
- W4317435897 hasConcept C512399662 @default.
- W4317435897 hasConcept C71924100 @default.
- W4317435897 hasConceptScore W4317435897C104863432 @default.
- W4317435897 hasConceptScore W4317435897C126322002 @default.
- W4317435897 hasConceptScore W4317435897C142724271 @default.
- W4317435897 hasConceptScore W4317435897C194828623 @default.
- W4317435897 hasConceptScore W4317435897C2777288759 @default.
- W4317435897 hasConceptScore W4317435897C2779457091 @default.
- W4317435897 hasConceptScore W4317435897C2780182762 @default.
- W4317435897 hasConceptScore W4317435897C2780221984 @default.
- W4317435897 hasConceptScore W4317435897C2780586474 @default.
- W4317435897 hasConceptScore W4317435897C2780868729 @default.
- W4317435897 hasConceptScore W4317435897C2991741193 @default.
- W4317435897 hasConceptScore W4317435897C512399662 @default.
- W4317435897 hasConceptScore W4317435897C71924100 @default.
- W4317435897 hasIssue "5" @default.
- W4317435897 hasLocation W43174358971 @default.
- W4317435897 hasOpenAccess W4317435897 @default.
- W4317435897 hasPrimaryLocation W43174358971 @default.
- W4317435897 hasRelatedWork W2145532404 @default.
- W4317435897 hasRelatedWork W2155855469 @default.
- W4317435897 hasRelatedWork W2331409909 @default.
- W4317435897 hasRelatedWork W2760183634 @default.
- W4317435897 hasRelatedWork W2765659125 @default.
- W4317435897 hasRelatedWork W2982059048 @default.
- W4317435897 hasRelatedWork W3000568411 @default.
- W4317435897 hasRelatedWork W4238477798 @default.
- W4317435897 hasRelatedWork W4238549103 @default.
- W4317435897 hasRelatedWork W4249487090 @default.
- W4317435897 hasVolume "6" @default.
- W4317435897 isParatext "false" @default.
- W4317435897 isRetracted "false" @default.
- W4317435897 workType "article" @default.